APA (7th ed.) Citation

Everts-Graber, J., Reichenbach, S., Gahl, B., Häuselmann, H., Ziswiler, H., Studer, U., & Lehmann, T. (2022). Effects of zoledronate on bone mineral density and bone turnover after long-term denosumab therapy: Observations in a real-world setting. BONE (8756-3282), 163, N.PAG. https://doi.org/10.1016/j.bone.2022.116498

Chicago Style (17th ed.) Citation

Everts-Graber, Judith, Stephan Reichenbach, Brigitta Gahl, HansJörg Häuselmann, Hans-Rudolf Ziswiler, Ueli Studer, and Thomas Lehmann. "Effects of Zoledronate on Bone Mineral Density and Bone Turnover After Long-term Denosumab Therapy: Observations in a Real-world Setting." BONE (8756-3282) 163 (2022): N.PAG. https://doi.org/10.1016/j.bone.2022.116498.

MLA (9th ed.) Citation

Everts-Graber, Judith, et al. "Effects of Zoledronate on Bone Mineral Density and Bone Turnover After Long-term Denosumab Therapy: Observations in a Real-world Setting." BONE (8756-3282), vol. 163, 2022, p. N.PAG, https://doi.org/10.1016/j.bone.2022.116498.